Figures and Tables

From the following article:

Bloodborne biomolecular markers in prostate cancer development and progression

Robert A. Bok & Eric J. Small

Nature Reviews Cancer 2, 918-926 (December 2002)

doi:10.1038/nrc951

Figure 1 - Bloodborne biomolecular markers in prostate cancer development and progression

Figure 1

Interaction of prostate cancer cells and bone cells in the formation of bone metastases, and release of various marker proteins into blood.

Figure 2 - Bloodborne biomolecular markers in prostate cancer development and progression

Figure 2

Functions of PSA in the normal prostate and in carcinogenesis.

Figure 3 - Bloodborne biomolecular markers in prostate cancer development and progression

Figure 3

Role of sex hormones in the development of prostate cancer.

Figure 4 - Bloodborne biomolecular markers in prostate cancer development and progression

Figure 4

Possible role of neuroendocrine elements in the development of prostate cancer.

Figure 5 - Bloodborne biomolecular markers in prostate cancer development and progression

Figure 5

IGF1 signalling.

Table 1 - Bloodborne biomolecular markers in prostate cancer development and progression

Table 1

Therapeutic approaches used in the treatment of prostate cancer